198 related articles for article (PubMed ID: 27583849)
1. Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment.
Gao L; Hao J; Niu YY; Tian M; Yang X; Zhu CH; Ding XL; Liu XH; Zhang HR; Liu C; Qin XM; Wu XZ
Medicine (Baltimore); 2016 Aug; 95(35):e4389. PubMed ID: 27583849
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients.
Liu J; Hao J; Niu Y; Wu X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2079-2092. PubMed ID: 33797608
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients.
Mao Y; Hao J; Jin ZQ; Niu YY; Yang X; Liu D; Cao R; Wu XZ
Oncotarget; 2017 Apr; 8(16):27007-27021. PubMed ID: 28212580
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology-Based and Clinically Relevant Prediction of the Potential Targets of Chinese Herbs in Ovarian Cancer Patients.
Sun J; Liu J; Liu D; Wu X
Biomed Res Int; 2020; 2020():8965459. PubMed ID: 33150184
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment.
Hung HY; Tseng YH; Liao CM; Chen SY; Wu TP; Lee YC; Chen YM
Integr Cancer Ther; 2017 Mar; 16(1):126-131. PubMed ID: 27151582
[TBL] [Abstract][Full Text] [Related]
6. [Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].
Zhao AG; Cao W; Xu Y; Zhao G; Liu BY; Cai Y; Yang JZ; Gu Y; Yuan W; Zhu YJ; Han YY; Yang JY
Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):224-30. PubMed ID: 20226143
[TBL] [Abstract][Full Text] [Related]
7. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of traditional Chinese herbal medicine (a herbal formula for invigorating spleen) for patients with advanced gastric cancer.
Xu Y; Zhao AG; Li ZY; Zhao G; Cai Y; Zhu XH; Cao ND; Yang JK; Zheng J; Gu Y; Han YY; Zhu YJ; Yang JZ; Gao F; Wang Q
Integr Cancer Ther; 2013 Sep; 12(5):414-22. PubMed ID: 22781545
[TBL] [Abstract][Full Text] [Related]
9. Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer.
Wang CY; Huang HS; Su YC; Tu CY; Hsia TC; Huang ST
Complement Ther Med; 2018 Oct; 40():29-36. PubMed ID: 30219465
[TBL] [Abstract][Full Text] [Related]
10. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA].
Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets of Chinese herbs: a clinical study of metastatic colorectal cancer based on network pharmacology.
Zhu H; Hao J; Niu Y; Liu D; Chen D; Wu X
Sci Rep; 2018 May; 8(1):7238. PubMed ID: 29740162
[TBL] [Abstract][Full Text] [Related]
12. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
Lu HL; Su YC; Lin MC; Sun MF; Huang ST
Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
[TBL] [Abstract][Full Text] [Related]
13. Exploration in the Mechanism of Kaempferol for the Treatment of Gastric Cancer Based on Network Pharmacology.
Yang L; Li H; Yang M; Zhang W; Li M; Xu Y; Li J; Kang J; Zhang J; Guo S
Biomed Res Int; 2020; 2020():5891016. PubMed ID: 33145355
[TBL] [Abstract][Full Text] [Related]
14. Effects of Chinese herbal medicine on hyperlipidemia and the risk of cardiovascular disease in HIV-infected patients in Taiwan.
Tsai FJ; Li TM; Cheng CF; Wu YC; Lai CH; Ho TJ; Liu X; Tsang H; Lin TH; Liao CC; Huang SM; Li JP; Lin JC; Lin CC; Liang WM; Lin YJ
J Ethnopharmacol; 2018 Jun; 219():71-80. PubMed ID: 29530610
[TBL] [Abstract][Full Text] [Related]
15. Effects of Chinese herbal medicine therapy on survival and hepatic outcomes in patients with hepatitis C virus infection in Taiwan.
Tsai FJ; Cheng CF; Chen CJ; Lin CY; Wu YF; Li TM; Chuang PH; Wu YC; Lai CH; Liu X; Tsang H; Lin TH; Liao CC; Huang SM; Li JP; Lin JC; Lin CC; Liang WM; Lin YJ
Phytomedicine; 2019 Apr; 57():30-38. PubMed ID: 30668320
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Chinese herbal medicine usage and its effect on survival of lung cancer patients in Taiwan.
Li TM; Yu YH; Tsai FJ; Cheng CF; Wu YC; Ho TJ; Liu X; Tsang H; Lin TH; Liao CC; Huang SM; Li JP; Lin JC; Lin CC; Liang WM; Lin YJ
J Ethnopharmacol; 2018 Mar; 213():92-100. PubMed ID: 29100936
[TBL] [Abstract][Full Text] [Related]
17. Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.
Shah MA; Janjigian YY; Stoller R; Shibata S; Kemeny M; Krishnamurthi S; Su YB; Ocean A; Capanu M; Mehrotra B; Ritch P; Henderson C; Kelsen DP
J Clin Oncol; 2015 Nov; 33(33):3874-9. PubMed ID: 26438119
[TBL] [Abstract][Full Text] [Related]
18. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
[TBL] [Abstract][Full Text] [Related]
19. Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Lorenzen S; Riera Knorrenschild J; Haag GM; Pohl M; Thuss-Patience P; Bassermann F; Helbig U; Weißinger F; Schnoy E; Becker K; Stocker G; Rüschoff J; Eisenmenger A; Karapanagiotou-Schenkel I; Lordick F
Eur J Cancer; 2015 Mar; 51(5):569-76. PubMed ID: 25694417
[TBL] [Abstract][Full Text] [Related]
20. Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in Taiwan.
Tsai FJ; Liu X; Chen CJ; Li TM; Chiou JS; Chuang PH; Ko CH; Lin TH; Liao CC; Huang SM; Liang WM; Lin YJ
Complement Ther Med; 2019 Dec; 47():102213. PubMed ID: 31780007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
